Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mariola Marcinkiewicz is active.

Publication


Featured researches published by Mariola Marcinkiewicz.


Journal of Biological Chemistry | 1999

EC3, a Novel Heterodimeric Disintegrin from Echis carinatus Venom, Inhibits α4 and α5 Integrins in an RGD-independent Manner

Cezary Marcinkiewicz; Juan J. Calvete; Mariola Marcinkiewicz; Manfred Raida; Senadhi Vijay-Kumar; Ziwei Huang; Roy R. Lobb; Stefan Niewiarowski

EC3, a heterodimeric disintegrin (M r = 14,762) isolated from Echis carinatus venom is a potent antagonist of α4 integrins. Two subunits called EC3A and EC3B were isolated from reduced and alkylated EC3 by reverse-phase high performance liquid chromatography. Each subunit contained 67 residues, including 10 cysteines, and displayed a high degree of homology to each other and to other disintegrins. EC3 inhibited adhesion of cells expressing α4β1 and α4β7 integrins to natural ligands vascular cell adhesion molecule 1 (VCAM-1) and mucosal addressin cell adhesion molecule 1 (MadCAM-1) with IC50 = 6–30 nm, adhesion of K562 cells (α5β1) to fibronectin with IC50 = 150 nm, and adhesion of αIIbβ3 Chinese hamster ovary cells to fibrinogen with IC50 = 500 nm; it did not inhibit adhesion of αvβ3 Chinese hamster ovary cells to vitronectin. Ethylpyridylethylated EC3B inhibited adhesion of Jurkat cells to immobilized VCAM-1 (IC50 = 6 μm), whereas EC3A was inactive in this system. The MLDG motif appeared to be essential for activity of EC3B. Linear MLDG peptide inhibited the adhesion of Jurkat to VCAM-1 in a dose-dependent manner (IC50 = 4 mm), whereas RGDS peptide was not active at the same concentration. MLDG partially inhibited adhesion of K562 cells to fibronectin (5–10 mm) in contrast to RGDS peptide (IC50 = 3 mm), inhibiting completely at 10 mm.


Biochemical Journal | 2002

Molecular cloning and biochemical characterization of rabbit factor XI.

Dipali Sinha; Mariola Marcinkiewicz; David Gailani; Peter N. Walsh

Human factor XI, a plasma glycoprotein required for normal haemostasis, is a homodimer (160 kDa) formed by a single interchain disulphide bond linking the Cys-321 of each Apple 4 domain. Bovine, porcine and murine factor XI are also disulphide-linked homodimers. Rabbit factor XI, however, is an 80 kDa polypeptide on non-reducing SDS/PAGE, suggesting that rabbit factor XI exists and functions physiologically either as a monomer, as does prekallikrein, a structural homologue to factor XI, or as a non-covalent homodimer. We have investigated the structure and function of rabbit factor XI to gain insight into the relation between homodimeric structure and factor XI function. Characterization of the cDNA sequence of rabbit factor XI and its amino acid translation revealed that in the rabbit protein a His residue replaces the Cys-321 that forms the interchain disulphide linkage in human factor XI, explaining why rabbit factor XI is a monomer in non-reducing SDS/PAGE. On size-exclusion chromatography, however, purified plasma rabbit factor XI, like the human protein and unlike prekallikrein, eluted as a dimer, demonstrating that rabbit factor XI circulates as a non-covalent dimer. In functional assays rabbit factor XI and human factor XI behaved similarly. Both monomeric and dimeric factor XI were detected in extracts of cells expressing rabbit factor XI. We conclude that the failure of rabbit factor XI to form a covalent homodimer due to the replacement of Cys-321 with His does not impair its functional activity because it exists in plasma as a non-covalent homodimer and homodimerization is an intracellular process.


Journal of Biological Chemistry | 2012

Productive Recognition of Factor IX by Factor XIa Exosites Requires Disulfide Linkage between Heavy and Light Chains of Factor XIa

Mariola Marcinkiewicz; Dipali Sinha; Peter N. Walsh

Background: The heavy chain of FXIa (FXIa-HC) is essential for efficient FIX activation, although the light chain (FXIa-LC) contains the active site. Results: Efficient FIX activation by FXIa occurred only when FXIa-HC and FXIa-LC were disulfide-linked. Conclusion: Substrate recognition by FXIa exosites requires disulfide-linked FXIa-HC and FXIa-LC. Significance: Covalent linkage between FXIa-HC and FXIa-LC is required to form the substrate binding exosite. In the intrinsic pathway of blood coagulation factor XIa (FXIa) activates factor IX (FIX) by cleaving the zymogen at Arg145-Ala146 and Arg180-Val181 bonds releasing an 11-kDa activation peptide. FXIa and its isolated light chain (FXIa-LC) cleave S-2366 at comparable rates, but FXIa-LC is a very poor activator of FIX, possibly because FIX undergoes allosteric modification on binding to an exosite on the heavy chain of FXIa (FXIa-HC) required for optimal cleavage rates of the two scissile bonds of FIX. However preincubation of FIX with a saturating concentration of isolated FXIa-HC did not result in any potentiation in the rate of FIX cleavage by FXIa-LC. Furthermore, if FIX binding via the heavy chain exosite of FXIa determines the affinity of the enzyme-substrate interaction, then the isolated FXIa-HC should inhibit the rate of FIX activation by depleting the substrate. However, whereas FXIa/S557A inhibited FIX activation of by FXIa, FXIa-HC did not. Therefore, we examined FIX binding to FXIa/S557A, FXIa-HC, FXIa-LC, FXIa/C362S/C482S, and FXIa/S557A/C362S/C482S. The heavy and light chains are disulfide-linked in FXIa/S557A but not in FXIa/C362S/C482S and FXIa/S557A/C362S/C482S. In an ELISA assay only FXI/S557A ligated FIX with high affinity. Partial reduction of FXIa/S557A to produce heavy and light chains resulted in decreased FIX binding, and this function was regained upon reformation of the disulfide linkage between the heavy and the light chains. We therefore conclude that substrate recognition by the FXIa exosite(s) requires disulfide-linked heavy and light chains.


PLOS ONE | 2016

A Novel Approach for Ovine Primary Alveolar Epithelial Type II Cell Isolation and Culture from Fresh and Cryopreserved Tissue Obtained from Premature and Juvenile Animals

Mariola Marcinkiewicz; Sandy T. Baker; Jichuan Wu; Terrence L. Hubert; Marla R. Wolfson

The in vivo ovine model provides a clinically relevant platform to study cardiopulmonary mechanisms and treatments of disease; however, a robust ovine primary alveolar epithelial type II (ATII) cell culture model is lacking. The objective of this study was to develop and optimize ovine lung tissue cryopreservation and primary ATII cell culture methodologies for the purposes of dissecting mechanisms at the cellular level to elucidate responses observed in vivo. To address this, we established in vitro submerged and air-liquid interface cultures of primary ovine ATII cells isolated from fresh or cryopreserved lung tissues obtained from mechanically ventilated sheep (128 days gestation—6 months of age). Presence, abundance, and mRNA expression of surfactant proteins was assessed by immunocytochemistry, Western Blot, and quantitative PCR respectively on the day of isolation, and throughout the 7 day cell culture study period. All biomarkers were significantly greater from cells isolated from fresh than cryopreserved tissue, and those cultured in air-liquid interface as compared to submerged culture conditions at all time points. Surfactant protein expression remained in the air-liquid interface culture system while that of cells cultured in the submerged system dissipated over time. Despite differences in biomarker magnitude between cells isolated from fresh and cryopreserved tissue, cells isolated from cryopreserved tissue remained metabolically active and demonstrated a similar response as cells from fresh tissue through 72 hr period of hyperoxia. These data demonstrate a cell culture methodology using fresh or cryopreserved tissue to support study of ovine primary ATII cell function and responses, to support expanded use of biobanked tissues, and to further understanding of mechanisms that contribute to in vivo function of the lung.


Biochemistry | 1999

Structural and functional characterization of EMF10, a heterodimeric disintegrin from Eristocophis macmahoni venom that selectively inhibits alpha 5 beta 1 integrin.

Cezary Marcinkiewicz; Juan J. Calvete; Senadhi Vijay-Kumar; Mariola Marcinkiewicz; Manfred Raida; Paul Schick; Roy R. Lobb; Stefan Niewiarowski


Journal of Biological Chemistry | 2004

A Subpopulation of Platelets Responds to Thrombin- or SFLLRN-stimulation with Binding Sites for Factor IXa

Fredda S. London; Mariola Marcinkiewicz; Peter N. Walsh


Thrombosis Research | 2001

Selective Recognition of α2β1 Integrin by Jararhagin, a Metalloproteinase/Disintegrin from Bothrops jararaca Venom

Ana M. Moura-da-Silva; Cezary Marcinkiewicz; Mariola Marcinkiewicz; Stefan Niewiarowski


Biochemistry | 2006

PAR-1-Stimulated Factor IXa Binding to a Small Platelet Subpopulation Requires a Pronounced and Sustained Increase of Cytoplasmic Calcium

Fredda S. London; Mariola Marcinkiewicz; Peter N. Walsh


Biochemistry | 2004

Allosteric Modification of Factor XIa Functional Activity upon Binding to Polyanions

Dipali Sinha; Karen O. Badellino; Mariola Marcinkiewicz; Peter N. Walsh


Biochemistry | 2005

Factor XIa dimer in the activation of factor IX.

Dipali Sinha; Mariola Marcinkiewicz; James D. Lear; Peter N. Walsh

Collaboration


Dive into the Mariola Marcinkiewicz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge